EGFR and non-small cell lung carcinoma: In addition, HGF, MET amplification, and EGFR T790M lead to the upregulation of PD-L1 expression in NSCLC and promote immune escape by tumor cells through different mechanisms mediated by the PI3K-Akt, MAPK, and NF-κB pathways [90].